Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Archivum Immunologiae Et Therapiae Experimentalis|April 9, 2013
Application of aptamers for targeted therapeuticsPartha Ray, Kristi D Viles, Erin E Soule, et al.
Nucleic Acid Therapeutics|November 20, 2015
Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable AnticoagulantErin E Soule, Kristin M Bompiani, Rebecca S Woodruff, et al.
Seminars in Thrombosis and Hemostasis|December 13, 2017
The Immunoregulatory Activities of Activated Protein C in Inflammatory DiseaseCormac J McDonnell, Erin E Soule, Patrick T Walsh, et al.
Cell Chemical Biology|February 3, 2022
Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samplesErin E Soule, Haixiang Yu, Lyra Olson, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
Activity of human immunodeficiency virus type 1 protease inhibitors against the initial autocleavage in Gag-Pol polyprotein processingDavid A Davis, Erin E Soule, Katharine S Davidoff, et al.
Plos One|November 3, 2010
The initial step in human immunodeficiency virus type 1 GagProPol processing can be regulated by reversible oxidationSarah I Daniels, David A Davis, Erin E Soule, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 8, 2013
Activation of virus uptake through induction of macropinocytosis with a novel polymerizing peptideSarah I Daniels, Erin E Soule, Katharine S Davidoff, et al.
Pageof 1